Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-15

FDA Approved: BUDESONIDE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

FDA approved a supplemental application for budesonide submitted by Padagis US LLC. The approval updates the labeling for budesonide under the supplemental subm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

SUPPL AP for BUDESONIDE (BUDESONIDE)